美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=TOFACITINIB CITRATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
TOFACITINIB CITRATE 220458 001 ANDA TOFACITINIB CITRATE TABLET, EXTENDED RELEASE;ORAL EQ 11MG BASE No No 2026/06/03 2026/06/03 APOTEX Prescription
TOFACITINIB CITRATE 220458 001 ANDA TOFACITINIB CITRATE TABLET, EXTENDED RELEASE;ORAL EQ 11MG BASE No No 2026/06/03 (TA) 2026/06/03 APOTEX Prescription
TOFACITINIB CITRATE 209829 001 ANDA TOFACITINIB CITRATE TABLET;ORAL EQ 5MG BASE No No 2026/06/05 2023/03/13 ZYDUS PHARMS Prescription
TOFACITINIB CITRATE 209829 002 ANDA TOFACITINIB CITRATE TABLET;ORAL EQ 10MG BASE No No 2026/06/05 2026/06/05 ZYDUS PHARMS Prescription
TOFACITINIB CITRATE 215552 001 ANDA TOFACITINIB CITRATE TABLET;ORAL EQ 5MG BASE No No 2026/06/09 2026/06/09 YAOPHARMA CO LTD Prescription
TOFACITINIB CITRATE 215552 002 ANDA TOFACITINIB CITRATE TABLET;ORAL EQ 10MG BASE No No 2026/06/09 2026/06/09 YAOPHARMA CO LTD Prescription
TOFACITINIB CITRATE 218821 001 ANDA TOFACITINIB CITRATE TABLET;ORAL EQ 5MG BASE No No 2026/06/09 2026/06/09 CONCORD BIOTECH LTD Prescription
TOFACITINIB CITRATE 218821 002 ANDA TOFACITINIB CITRATE TABLET;ORAL EQ 10MG BASE No No 2026/06/09 2026/06/09 CONCORD BIOTECH LTD Prescription
TOFACITINIB CITRATE 218900 001 ANDA TOFACITINIB CITRATE SOLUTION;ORAL EQ 1MG BASE/ML No No 2026/06/09 2026/06/09 SAPTALIS PHARMS Prescription
TOFACITINIB CITRATE 219370 001 ANDA TOFACITINIB CITRATE SOLUTION;ORAL EQ 1MG BASE/ML No No 2026/06/09 2026/06/09 AUSON Prescription
TOFACITINIB CITRATE 219830 001 ANDA TOFACITINIB CITRATE TABLET, EXTENDED RELEASE;ORAL EQ 11MG BASE No No 2026/06/09 2026/06/09 ORIENT PHARMA Prescription
TOFACITINIB CITRATE 219830 001 ANDA TOFACITINIB CITRATE TABLET, EXTENDED RELEASE;ORAL EQ 11MG BASE No No 2026/06/09 (TA) 2026/06/09 ORIENT PHARMA Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2026 DrugFuture->U.S. FDA Drugs Database